Bluejay Investor Presentation Deck

SymphonyTM Product Pipeline ●●● Products TM Symphony ™M IL-6 Test patient acuity for sepsis triage/monitoring Symphony TM hsTNT/I patient acuity with chest pain TM Symphony ™M NT-proBNP patient acuity with chest pain DIAGNOSTICS Research Other well-validated critical care biomarkers Development New Tests Will Follow the IL-6 Development Pathway. Plan to expand testing menu to include: The Symphony™ System and SymphonyTM Cartridge have not been cleared or approved by the U.S. FDA Clinical Testing Regulatory Tests with potential clinical and cost-saving benefits gained from faster turnaround times Copyright ©2023 Bluejay Diagnostics, Inc. All rights reserved in all slides | June 2023 13

View entire presentation